Prolonged or uncontrolled B-cell receptor (BCR) signaling is associated with autoimmunity. We previously demonstrated a role for actin in BCR signal attenuation. This study reveals that actin-binding protein 1 (Abp1/HIP-55/SH3P7) is a negative regulator of BCR signaling and links actin to negative regulatory pathways of the BCR. In both Abp1
B
cells are responsible for mounting antibody (Ab) responses towards invading pathogens. Antigen (Ag) binding to B-cell receptors (BCRs) induces rapid reorganization of surface BCRs into microclusters (1) and the interaction of the BCR with lipid raft-resident kinases, initiating signaling required for B-cell survival and proliferation (2, 3) . BCR signaling is tightly regulated, and elevated or sustained BCR signaling has been shown to be associated with autoimmunity (4) . Attenuation of BCR signaling is mediated by various phosphatases and kinases, including SH2-containing inositol 5-phosphatase (SHIP-1) (5) and hematopoietic progenitor kinase 1 (HPK1) (6) . SHIP-1 inhibits activation of phospholipase-Cγ2 (PLCγ2), Bruton's tyrosine kinase, and Akt by eliminating their membrane docking sites, consequently blocking their downstream signaling (5) . SHIP deficiency causes hyperresponsiveness and impaired affinity maturation of B cells in germinal centers (GCs) (7) . HPK1 inhibits BCR signaling by inducing phosphorylation and subsequent ubiquitination of B-cell linker protein (BLNK) (6) , the key adaptor molecule of the BCR. HPK1 deficiency results in elevated levels of activated BLNK, MAP kinases, B-cell proliferation, and resultant susceptibility to induced autoimmunity (6) . BCR clustering is also involved in negative regulation, as we recently demonstrated that coalescence of BCR microclusters into a central cluster facilitates BCR signal attenuation. This coalescence requires actinmediated B-cell contraction and SHIP-1 activation (8, 9).
Actin is critical for both amplification and attenuation of BCR signaling. BCR-induced disassembly of cortical actin enables BCR microcluster formation and signal activation (1, 10, 11) . Actin reassembly expands the contact of B cells with Ag-presenting surfaces and induces polarized movement of surface BCRs, enhancing BCR clustering and signaling (8-10, 12, 13) . Upon maximal cell spread, F-actin decreases in the B-cell region contacting Ag-presenting surfaces, and the cells contract, facilitating coalescence of BCR microclusters and signal attenuation (1, 8, 9, 13) . Persistent actin accumulation at the B-cell contact zone and delayed cell contraction, caused by B-cell-specific neuronal Wiskott-Aldrich syndrome protein (N-WASP) knockout, lead to enhanced BCR signaling and elevated levels of autoantibody (autoAb) (14) . These data indicate that actin remodeling coordinates with the reorganization and signaling of surface BCRs, but how actin attenuates BCR signaling remains elusive.
Abp1 is an adaptor protein that contains multiple interaction domains, including an actin-depolymerizing factor homology, helical, proline-rich, and SH3 domains (15) (16) (17) . Its ability to simultaneously bind F-actin and proline-rich-domain-containing molecules implicates a role for Abp1 in actin-BCR communication. A role for Abp1 in lymphocyte signaling was first demonstrated in Abp1-deficient T cells, which display decreased signaling, proliferation, cytokine production, and T-celldependent Ab responses (18) . Abp1 is responsible for recruiting HPK1 to the immunological synapse of T cells (19) . In B cells, BCR activation induces the recruitment and phosphorylation of Abp1 (15, 20) , which is required for BCR-mediated Ag Significance B cells are the major mediators of humoral immunity, producing antibody to aid in the elimination of pathogens. B cells signal through their membrane receptors, resulting in transcriptional modification for the maintenance of B-cell survival, proliferation, and antibody production. B-cell receptor (BCR) signaling is tightly regulated, and elevated or sustained BCR signals lead to loss of B-cell tolerance and subsequent autoimmunity. This study reveals that the adaptor molecule Abp1 negatively regulates development of marginal zone and spontaneous germinal center B cells, as well as autoantibody production. As a link between the actin cytoskeleton and BCR signaling, Abp1 assists BCR signal attenuation by promoting BCR central cluster formation, as well as recruitment of inhibitory signaling molecules to BCR signalosomes.
internalization (20) . However, how Abp1 contributes to BCR signaling remains unexplored.
This study demonstrates that Abp1 is a negative regulator of BCR signaling and B-cell activation. Abp1 −/− B cells display greater levels of BCR signaling than wild-type (wt) B cells, which correlates with increased numbers of spontaneously formed GC B cells and autoAb production in Abp1 −/− mice and bone marrow chimeric mice. Abp1 attenuates BCR signaling by promoting BCR microcluster coalescence and B-cell contraction and recruiting the inhibitory molecules SHIP-1 and HPK1 to BCR microclusters. Thus, our results reveal Abp1 as a novel mechanistic link between actin remodeling and negative signaling, exerting a B cell-intrinsic inhibition on B-cell activation. −/− mice (18), but whether Abp1 contributes to B-cell development has not been fully examined. The numbers and percentages of various B-cell subpopulations in the bone marrow, spleen, and peritoneal cavity (PerC) from Abp1 −/− and agematched wt mice were analyzed by flow cytometry ( Fig. 1 and Fig. S1 ). Abp1 −/− mice had normal percentages of all B-cell subsets in the bone marrow ( Fig. S1 A and B) . The numbers of splenic transitional 1 (T1) and 2 (T2), follicular, and isotype switched B cells were unaffected in Abp1 −/− mice; however, the number of marginal zone (MZ) B cells was increased compared with wt mice (Fig. 1A and Fig. S1C ). The number of B1a B cells in the PerC was also increased compared with wt mice (Fig. 1B  and Fig. S1D ). In addition, Abp1 expression levels in mature B cells of the spleen were much higher than those in pro-and pre-B cells (Fig. S1E) , suggesting the defect observed in peripheral B-cell development in Abp1 −/− mice may be related to differential expression of Abp1 in different B-cell subsets.
As mature B cells are activated in follicles to form GCs, we examined the number of GC B cells in the spleen of nonimmunized mice, using flow cytometry and immunohistochemistry. Nonimmunized Abp1 −/− mice had significantly higher numbers of splenic GC B cells than wt mice (Fig. 1C and Fig. S1F ). Consistent with this result, immunohistological examination showed increased numbers and larger sizes of PNA + GCs in Abp1 −/− spleens compared with wt ( Fig. 1 D and E) . Abp1 −/− mice also exhibit splenomegaly (Fig. S1G) .
To examine whether the phenotype observed in Abp1 −/− mice is B-cell intrinsic, we generated bone marrow chimeric mice (21 -Ch mice displayed higher numbers of spontaneous GC and MZ B cells (Fig. 1F) in the spleen compared to those in wt chimeric mice (wt-Ch).
Taken together, these results suggest that Abp1 exerts a B-cell-intrinsic inhibition on the spontaneous development of GC B cells and differentiation of MZ and B1a B cells but is not involved in early B-cell maturation in the bone marrow.
Production of AutoAb, T-Independent Ab Responses and Total Ab Increase While T-Dependent High-Affinity Ab Responses Decrease in Abp1 −/− Mice. Spontaneous GC formation has been described as a characteristic of autoimmune-susceptible mouse strains (22) . To test this possibility, we evaluated autoAb production in -Ch by flow cytometry (+SD; n = 3). *P < 0.05; **P < 0.01; ***P < 0.001. 30 by ELISA (+SD; n = 4∼5). *P < 0.05; **P > 0.01; ***P < 0.001.
nonimmunized wt and Abp1
−/− mice. Using an antinuclear Ab slide test (ANA), we found that Abp1 −/− mice tested ANApositive much earlier, with 50% positive by 6 mo of age compared with 0% of wt mice ( Fig. 2A) . Quantitative ELISA analysis showed that nonimmunized Abp1 −/− mice had significantly higher anti-dsDNA Ab production than wt mice by 6 mo of age (Fig. 2B) . Furthermore, Abp1 −/− -Ch mice also showed elevated levels of anti-dsDNA Ab compared with wt-Ch mice 4 mo after bone marrow transplant (Fig. 2B) .
To examine whether increased MZ, B1a, and GC B cells in Abp1 −/− mice affect Ab responses, we immunized mice with the T-independent Ag 4-hydroxy-3-nitrophenylacetyl (NP) conjugated to Ficoll once or the T-dependent Ag NP conjugated to Keyhole Limpet Hemocyanin (KLH) twice, 28 d apart, and quantified NP-specific and total IgM and/or IgG in the serum, using ELISA. In response to NP-Ficoll, Abp1 −/− mice exhibited significant increases in both NP-specific (Fig. 2C ) and total IgM (Fig. 2D ) compared with wt mice. In response to NP-KLH, Abp1 −/− mice showed slightly elevated Ag-specific IgM at day 35, but total IgM was significantly increased throughout the time course compared with wt mice (Fig. 2 E and F) . Similar to a previous report (18) , serum levels of Ag-specific IgG were decreased in Abp1 −/− mice compared with wt mice (Fig. 2G ). This decrease was especially dramatic after the boost, indicating that the secondary response is more severely affected by Abp1 deficiency. In contrast, the level of total IgG was significantly elevated in Abp1 −/− mice during both primary and secondary Ab response (Fig. 2H) . We further evaluated Ab affinity in NP-KLH immunized mice by determining the ratio of Ab binding to lowvalent (NP 4 ) and high-valent (NP 30 ) Ag by ELISA. The ratio was significantly increased in wt mice but not in Abp1 −/− mice after the boost (Fig. 2I) . Thus, Abp1 −/− mice display impaired affinity maturation and mount defective T-dependent Ab responses but elevated T-independent, nonspecific, and self-reactive Ab responses.
Abp1 Deficiency Augments B-Cell Spread and BCR Clustering. As the increased production of spontaneous GC B cells and autoAb is a B-cell-intrinsic effect, we further examined the effect of Abp1 deficiency on early events of BCR-mediated B-cell activation, including BCR clustering and B-cell morphological changes. We labeled and cross-linked surface BCRs using Alexa Fluor 546-labeled, monobiotinylated Fab' fragment of anti-mouse IgG+M Ab (AF546-mB-Fab'-anti-Ig) tethered to planar lipid bilayers (Fab'-anti-Ig-tethered lipid bilayers). Interference reflection microscopy (IRM) was used to analyze the area of the B-cell membrane that contacts the Fab'-anti-Ig-tethered surface (B-cell contact zone), which reflects B-cell spreading and contraction, as well as total internal reflection fluorescence microscopy (TIRF) to quantify relative amounts of BCRs clustered in the contact zone. We also analyzed BCR clustering in B cells stimulated with AF546-mB-Fab'-anti-IgG+M cross-linked by soluble streptavidin, using confocal microscopy. We found that the contact area of Abp1 −/− B cells did not reduce after 3 min of activation, as did that of wt B cells, indicating an inhibition of cell contraction ( Fig.  3 A and B) . Total fluorescence intensity (TFI) of labeled BCRs in the contact zone of Abp1 −/− B cells continuously increased over time compared with wt B cells which reached a plateau at 3 min and decreased by 9 min (Fig. 3C) . However, the mean fluorescence intensity (MFI) of BCR staining in the contact zone of Abp1 −/− B cells was lower than that of wt B cells (Fig. 3D ). Labeled BCRs remained punctate throughout the contact zone of Abp1 −/− B cells and did not coalesce into a central cluster by 7 min, as in wt B cells (Fig. 3A) . In response to soluble BCR cross-linking, a significantly higher percentage of Abp1 −/− B cells showed polarized BCR caps compared with wt B cells ( Abp1 Is Recruited to B-Cell Contact Zone upon BCR Activation. To understand the mechanism by which Abp1 contributes to BCR signaling, we examined the spatial relationship of Abp1 with BCRs at the cell surface. Upon incubation with Fab'-anti-Igtethered lipid bilayers, Abp1 was recruited to the B-cell contact zone (Fig. 4A ). Although the contact zone area and size of BCR clusters changed over time, Abp1 predominantly accumulated at the outer edge of the contact zone and did not significantly colocalize with surface BCRs throughout the activation process ( Fig. 4 A and B ). Abp1 MFI rose over time, with a dramatic peak of recruitment at 7 min, concurrent with B-cell contraction but long after peak BCR TFI and maximal B-cell spreading (Figs. 3 B and C and 4C). These results indicate that Abp1 is specifically recruited to the periphery of the B-cell membrane, predominantly during B-cell contraction, in response to BCR activation. −/− B cells displayed higher Ca 2+ flux than their wt counterparts (Fig. 5F ). There was no significant difference in the expression levels of membrane IgM, BLNK, MEK1/2, Erk, and Jnk between resting Abp1 −/− and wt B cells (Fig. S5 A-E). This result indicates that the enhanced signaling in Abp1 −/− B cells suggests a negative regulatory role for Abp1 in BCR signaling. One possible mechanism by which Abp1 may negatively regulate signaling is by modulating inhibitory signaling molecules downstream of the BCR. To test this hypothesis, we examined the effects of Abp1 deficiency on the recruitment of two known inhibitory molecules, HPK1 and SHIP-1, to the B-cell contact zone using TIRF. Upon interaction with Fab'-anti-Ig-tethered lipid bilayers, the MFI of both HPK1 (Fig. 6 A and B) and phosphorylated SHIP-1 (pSHIP-1) (Fig. 6 C and D) in the contact zone of wt B cells increased over time, peaking by 7 min, and then reducing by 9 min. Although Abp1 −/− B cells displayed the same trend of HPK1 recruitment, its MFI in the contact zone was significantly reduced throughout the time course. Similarly, the peak MFI of pSHIP in Abp1 −/− B cells at 7 min was drastically reduced compared with wt B cells. However, Abp1 deficiency had no significant effect on the recruitment of phosphorylated spleen tyrosine kinase (pSyk) to BCR clusters ( Fig. 6 E and F) , as well as the expression levels of HPK1 and SHIP (Fig. S5 F and G) . These results indicate that Abp1 is required for the recruitment and activation of the key inhibitory molecules HPK1 and SHIP-1 downstream of BCR stimulation.
BCR Signaling Is Enhanced in
Abp1 Regulates BCR-Induced Actin Reorganization. Increased B-cell spreading and BCR clustering at the surface of Abp1 −/− B cells, which are actin-dependent events, suggest a role for Abp1 in BCR-induced actin remodeling. To investigate this hypothesis, we examined the effects of Abp1 deficiency on F-actin accumulation at the B-cell contact zone using TIRF. In wt B cells, F-actin MFI in the contact zone peaked at ∼3 min of incubation with Fab'-anti-Ig-tethered lipid bilayers, when B-cell spreading is maximal, and then reduced as B cells contracted ( Fig. 7 A and  B) . In contrast, F-actin MFI in the contact zone of Abp1 −/− B cells rose slowly, did not peak until ∼7 min, and remained at peak levels through 9 min. As levels of F-actin in resting B cells were not altered by Abp1 deficiency (Fig. S5H) , our data suggest that Abp1 may primarily contribute to signal-induced actin remodeling, both early accumulation and later clearance of F-actin from the B-cell contact zone.
Abp1 has been shown to regulate actin dynamics by interacting with the actin nucleation promoting factor N-WASP in neurons (23) . Our recent studies demonstrate that WASP plays a dominant role in actin assembly during B-cell spreading, but N-WASP has a unique role in actin clearance during B-cell contraction (14) . To investigate whether Abp1 regulates actin remodeling via WASP and N-WASP, we analyzed the effect of Abp1 deficiency on the recruitment and phosphorylation of WASP (pWA) and N-WASP (pN-WA) by TIRF. In wt B cells, pWASP MFI peaked first at ∼5 min, followed by pN-WASP, which peaked at ∼7 min ( Fig. 7 C-F) (14) . In Abp1 −/− B cells, pWASP MFI increased with the same kinetics and to similar levels as wt B cells but reduced more slowly after reaching maximal levels compared with wt ( Fig. 7 C and D) . In contrast, pN-WASP MFI in the contact zone of Abp1 −/− B cells was significantly lower than wt B cells ( Fig. 7 E and F) . Flow cytometry analysis further confirmed reduced levels of pN-WASP in Abp1 −/− B cells (Fig. S6) . However, Abp1 deficiency has no significant effect on basal expression levels of WASP and N-WASP (Fig. S5 I and J) . These results suggest that Abp1 regulates BCR-induced actin remodeling by suppressing WASP activation, which induces F-actin accumulation and B-cell spreading, and by enhancing N-WASP activation, which triggers actin clearance and B-cell contraction.
Discussion
Abp1, an actin-binding adaptor protein expressed widely from yeast to mammalian cells, has been implicated in a multitude of cellular functions, including endocytosis (19, 20, 24, 25) , synaptic vesicle recycling (25) , phagocytosis (26) , cell migration (27, 28) , and T-cell activation (18, 19) . This study reveals a novel function for Abp1, attenuation of BCR signaling, which contributes to the regulation of peripheral B-cell differentiation and Ab responses. −/− B cells, our results support the notion that Abp1-mediated down-regulation of BCR signaling directly influences the differentiation of these peripheral B-cell subsets. These data also suggest that Abp1 is potentially involved in suppressing Ag-independent signals required for the differentiation of GC, MZ, and B1a B cells. Actin dynamics are known to regulate tonic BCR signaling via modulating BCR-BCR and BCR-CD19 interactions (29) . Thus, it is possible that Abp1 regulates tonic signaling in resting B cells by modulating actin dynamics and receptor interactions. Additional research is required to address these questions.
Failure of Abp1 −/− mice to generate high-affinity Ab while simultaneously producing high levels of nonspecific IgG during T-dependent Ab responses indicates defective affinity maturation. In GCs, B cells with higher-affinity BCRs are selected to survive and differentiate because of a greater ability to signal and capture/present Ag to T cells than low-affinity B cells (30) . Enhanced/prolonged BCR signaling in Abp1 −/− B cells may interfere with affinity-dependent signal regulation. Reductions in Ag uptake and presentation (20) likely ablate the ability of Abp1 −/− B cells to acquire T-cell help. Impairment in the activation of Abp1 −/− T cells may further exacerbate the affinity maturation defect observed in Abp1 −/− mice. The affinity maturation defect provides another possible explanation for increased levels of autoAb in Abp1 −/− mice, as Ag-specific B cells are not preferentially selected from B-cell pools that also contain autoreactive B cells.
The negative regulatory function of Abp1 in BCR signaling demonstrated here is in contrast to its positive role in T-cell receptor (TCR) activation (18) . Although T-cell development is largely unchanged in Abp1 −/− mice, TCR-induced phosphorylation of the linker for activation of T cells LAT and PLCγ1, and activation of the MAP kinases JNK and p38, are partially defective, and T-cell proliferation and cytokine production are reduced (18) . Similar to T cells (18) , Abp1 deficiency does not have a significant effect on early B-cell development; however, BCR signaling is enhanced in Abp1 −/− B cells upon in vitro stimulation, exhibiting higher levels of tyrosine and BLNK phosphorylation. Although JNK phosphorylation is decreased, similar to Abp1 −/− T cells, Abp1 −/− B cells display faster kinetics and higher levels of ERK phosphorylation than wt B cells. The Abp1 −/− mice used here were generated by the laboratory that reported the T-cell study (18) , and therefore, opposing functions in T and B cells cannot be attributed to differences in the mouse model. Although the molecular mechanisms underlying differential regulation of BCR and TCR signaling remain elusive, our results demonstrate cell type-specific functions for Abp1 in signal regulation.
This and previous studies (16, 18, 20, 23, 24) suggest three mechanisms by which Abp1 may promote signal attenuation, including modulating actin dynamics and actin-dependent early BCR activation events, the recruitment of inhibitory signaling molecules, and BCR internalization. We previously demonstrated that although BCR clustering initiates signaling, the subsequent coalescence of BCR microclusters into central clusters attenuates signaling (8, 9, 14) . Formation of BCR clusters depends on actin remodeling, which controls lateral movement of BCRs and mediates B-cell morphological changes. B-cell spreading amplifies BCR clustering, and B-cell contraction drives microcluster coalescence (8, 9, 13) . This study shows that Abp1 is not required for BCR microcluster formation and B-cell spreading, but instead facilitates B-cell contraction and BCR microcluster coalescence. Abp1-mediated signal attenuation may be attributed to its role in actin remodeling, where Abp1 plays a more prominent role in actin clearance rather than actin accumulation in the B-cell contact zone. In support of this hypothesis, failure to clear F-actin in the contact zone of N-WASP −/− B cells has been linked to enhanced and prolonged BCR signaling (14) .
How Abp1 regulates BCR-induced actin remodeling is not fully understood. Although yeast Abp1 directly activates Arp2/3 (31), mammalian Abp1 may regulate actin polymerization indirectly by interactions with N-WASP, as reported in neurons (23) . Unlike neurons, immune cells express both N-WASP and its hematopoietic homolog WASP, and the two have distinct functions in B cells. WASP activates actin assembly and B-cell spreading, whereas N-WASP promotes F-actin clearance and B-cell contraction. Furthermore, these two negatively regulate one another (14) . We show here that levels of active WASP and N-WASP are increased and decreased in Abp1 −/− B cells, respectively. This suggests that Abp1 preferentially promotes N-WASP activation, which suppresses WASP activation. Similar recruitment kinetics for N-WASP (14) and Abp1 to the B-cell contact zone and similar phenotypes observed in Abp1 −/− and N-WASP −/− mice further support a functional relationship between the two and the notion that Abp1 modifies actin remodeling by regulating N-WASP.
Abp1 is responsible for bringing HPK1 to the immunological synapse of T cells (19) . We confirm here that Abp1 has a similar role in B cells. Activated HPK1 is known to phosphorylate BLNK, leading to ubiquitination and down-regulation of BLNK (6). Although we did not directly examine HPK1 activation here, elevated levels of phosphorylated BLNK and ERK, and Ca by perturbing actin and N-WASP −/− enhances signaling (9, 14, 32) . Abp1 facilitates BCR internalization by bridging actin and dynamin 2 at constricted necks of endocytosing vesicles (20, 24, 26) . Although Abp1 likely uses multiple mechanisms in downregulating BCR signaling, it should be noted that these mechanisms are likely interrelated: Abp1-modulated actin remodeling may be important for recruitment of HPK1 and SHIP-1, and recruited inhibitory signaling molecules can regulate actin remodeling and actinmediated cellular events.
This study further demonstrates the importance of actin in negative regulation of B-cell activation and identifies Abp1 as a missing link between actin and signal attenuation mechanisms, which expands our understanding of the molecular mechanisms underlying negative regulation of B-cell activation.
Materials and Methods
Mice and Cell Culture. Abp1 knockout mice (Abp1 −/− ) were previously described (18) . All other mice were purchased from Jackson Laboratory. Splenic B cells were enriched, and bone marrow and peritoneal cells were flushed from femurs and PerCs, respectively. All animal work was approved by the Institutional Animal Care and Use Committee of the University of Maryland.
Flow Cytometry. Cells were preincubated with Fcγ receptor block (BD Bioscience) and stained with Abs specific for different surface markers at 4°C. To stain intracellular molecules, cells were activated with F(ab') 2 -goat antimouse IgG+M (Jackson ImmunoResearch), fixed, permeabilized, and labeled with Abs specific for signaling molecules or Abp1 (20) . Cells were analyzed using a FACSCanto flow cytometer (BD Biosciences).
Immunohistochemistry. Spleens embedded in optimum cutting temperature compound OCT (Sakura Finetek) were sectioned using a cryostat. Samples were fixed, stained with fluorescently conjugated Abs, and imaged using a Zeiss LSM710 confocal microscope.
Serological Analysis and Immunizations. Antinuclear Abs were detected using ANA (HEp-2) slides (MBL-Bion). Levels of anti-dsDNA Abs were quantified by ELISA (21) . Mice were immunized (intraperitoneally) with (4-hydroxy-3-nitrophenyl)acetyl conjugated to Ficoll or keyhole limpet hemocyanin (NP-Ficoll or NP-KLH; Biosearch Technologies) in PBS or Sigma Adjuvant (Sigma-Aldrich), respectively, and boosted on day 28 (NP-KLH only). Levels of NP-specific and total IgM and IgG Abs were determined by ELISA. Relative affinity was assessed as the concentration ratio of IgG bound to NP 4 -versus NP 30 Total Internal Reflection Fluorescence Microscopy. Alexa Fluor 546-conjugated, monobiotinylated Fab' fragment of anti-mouse antibody (AF546-mBFab'-anti-IgG+M) tethered to planar lipid bilayers was generated to stimulate B cells, as previously described (33) . Images were acquired using a Nikon laser TIRF system (Nikon TE2000-PFS, 60× TIRF objective). For intracellular molecules, B cells were fixed, permeabilized, and stained with specific Abs or AF488-phalloidin for F-actin. Total or mean fluorescence intensity was determined using Andor iQ software (Andor Technology).
Confocal Microscopic Analysis. Splenic B cells were stained with AF546-mBFab'-anti-IgG+M for surface BCRs and streptavidin to activate and were analyzed with a confocal microscope.
Calcium Analysis. Calcium flux was analyzed with Fluo4 AM and Fura Red (Invitrogen), using manufacturer's protocols and a flow cytometer (BD Biosciences).
For detailed materials and methods, see SI Materials and Methods.
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Mice and Cell Culture. Wild-type (wt) C57BL/6 mice expressing either CD 45.1 or CD 45.2 and B-cell null μMT mice were purchased from the Jackson Laboratory. Abp1 knockout mice (Abp1 −/− ) were generated and crossed onto a C57BL/6 background, as previously described (1). To isolate splenic B cells, single-cell suspensions of splenocytes were subjected to densitygradient centrifugation in Ficoll (Sigma-Aldrich) to obtain mononuclear cells, treated with anti-Thy1.2 mAb (BD Biosciences) and guinea pig complement (Rockland Immunochemicals) to remove T cells, and panned for 2 h to remove monocytes. Bone marrow (BM) was flushed from mouse femurs with PBS supplemented with 3% (vol/vol) FBS and subjected to density-gradient centrifugation in Ficoll (2). Peritoneal cells were flushed from the peritoneal cavity with PBS supplemented with 3% FBS (3). All animal work was reviewed and approved by the Institutional Animal Care and Use Committee of the University of Maryland.
Flow Cytometry. For flow cytometric analyses, cell suspensions from BM, spleen, or peritoneal cavity were incubated with Fcγ receptor (FcγR) blocking Abs (anti-mouse CD16/CD32; BD Bioscience) on ice and stained at optimal dilutions of conjugated Abs in PBS supplemented with 1% FBS. Anti-mouse Abs and reagents used to stain BM cells included Pacific Blue-anti-CD24 (BioLegend), biotinylated anti-Ly-51, streptavidin-phycoerythrin (PE), FITC-anti-CD43, PerCP (peridinin chlorophyll protein complex)-Cy5.5-anti-B220, and allophycocyanin (APC)-anti-IgM (BD Biosciences) (4, 5) . Anti-mouse Abs and reagents used to stain transitional 1 (T1), transitional 2 (T2), follicular (FO), and isotype switched (IS) splenic B cells included biotinylated-antiIgD (Southern Biotech), Alexa Fluor (AF)405-streptavidin (Life Technologies), PerCP-Cy5.5-anti-B220, and FITC-anti-IgM (BD Biosciences) (6) . Anti-mouse Abs and reagents used to stain splenic marginal zone B cells (MZ) included Pacific Blue-anti-CD21 (BioLegend), PerCP-Cy5.5-anti-B220, and PE-anti-CD23 (BD Biosciences) (6). Anti-mouse Abs and reagents to stain B1a and B1b cells from the peritoneal cavity included biotinylatedanti-IgD (Southern Biotech); PE-Cy5-streptavidin, FITC-antiIgM, and APC-anti-CD5 (BD Biosciences); and eFlour 450-anti-CD11b (eBiosciences) (7). Anti-mouse Abs and reagents to stain splenic germinal center B cells (GCs) included biotinylatedanti-CD95 (BD Biosciences) AF488-streptavidin (Invitrogen), PE-anti-GL7, and PerCP-Cy5.5-anti-B220 (BD Biosciences) (8) .
To determine the level of Abp1 expression in each B-cell subset, the preceding samples were fixed with 4% (wt/vol) paraformaldehyde, permeabilized with 0.05% saponin, and stained with goatanti-Abp1 Ab, followed by fluorescently conjugated secondary Ab. Goat-anti-mouse Abp1 Ab was generated by immunization of a goat with GST-Abp1 fusion proteins by Alpha Diagnostics International and purified using protein G-Sepharose column (9) .
To analyze intracellular signaling molecules, splenic B cells were incubated with FcγR blocking mAb at 4°C, stained with APC anti-mouse CD19 Ab (BD Biosciences) to label B cells, washed, activated with 10 μg/mL F(ab') 2 -goat-anti-mouse IgG+ M (Jackson ImmunoResearch), fixed, and stained with Abs specific for phosphotyrosine mAb 4G10 (EMD Millipore), phosphorylated B-cell linker protein (pBLNK) (Santa Cruz Biotechnology), phosphorylated mitogen-activated protein kinase kinase MEK1/2 (pMEK1/2), pERK, pp38, or pJNK (Cell Signaling Technology), followed by fluorescently conjugated secondary Abs. Cells were pretreated and treated during stimulation with the MEK1/2 (U0126, 10 μM; InvivoGen) or JNK (SP600125, 10 μM; A.G. Scientific Inc.) as controls to confirm specificity of pERK and pJNK Ab labeling.
To determine the expression levels of membrane IgM (mIgM), signaling, and actin-related molecules in unstimulated splenic B cells, B cells were treated with FcγR-block Ab, labeled with PerCP Cy5.5 anti-mouse B220 Ab, fixed, permeabilized, and labeled with Abs or reagents, including anti-mouse IgM (BD Biosciences), anti-BLNK, anti-SH2-containing inositol 5-phosphatase (SHIP), anti-Wiskott-Aldrich syndrome protein (WASP), anti-N-WASP (Santa Cruz Biotechnology), anti-MEK, anti-ERK, anti-JNK, and anti-HPK1 (Cells Signaling Technologies), and AF488 Phalloidin for F-actin (Life Technologies), followed by fluorescently conjugated secondary Abs where necessary.
Cells were analyzed with a FacsCanto flow cytometer and FACSDiva Software (BD Biosciences) or FlowJo (Tree Star).
Immunohistochemistry. Spleens from wt and Abp1
−/− mice were embedded in optimum cutting temperature compound (Sakura Finetek) and frozen in liquid nitrogen. Sections (10 μm) were collected using a cryostat. Samples were fixed in acetone, blocked with goat serum (Jackson ImmunoResearch) and avidin/biotin (Sigma Aldrich), and then stained with optimal concentrations of the following Abs/reagents: biotinylated-antiIgD (Southern Biotech), AF405-streptavidin (Life Technologies), AF488-anti-Thy1.2 (eBioscience), and AF647-PNA (Life Technologies). Cells were imaged using a Zeiss LSM 710 Confocal Microscope (Carl Zeiss Microscopy, Jenna, Germany). GC size was calculated using Zen Lite 2011 Software (Carl Zeiss Microcopy).
Bone Marrow Chimera Mice. BM chimeric mice were generated using a previously published method (10) . C57BL/6 wt recipient mice expressing CD45.1 were lethally irradiated (1,000 cGy). BM from Apb1 −/− or wt mice (CD45. -Ch were quantified by ELISA, using a previously published protocol (10) . Briefly, ELISA plates were precoated at 4°C with dsDNA (10 μg/mL; Sigma-Aldrich). After blocking, the plates were incubated with diluted triplicate serum samples and goat anti-mouse IgG-HRP (Jackson ImmunoResearch). HRP was detected using OptEIA TMB substrate (BD Bioscience).
Immunizations and ELISA. To analyze T-cell-independent and T-cell-dependent antigen responses, mice were immunized by intraperitoneal injection of (4-hydroxy-3-nitrophenyl)acetyl conjugated to either Ficoll (NP-Ficoll, T-cell-independent antigen) or keyhole limpet hemocyanin (NP-KLH, T-celldependent antigen; Biosearch Technologies) in PBS or Sigma Adjuvant System (Sigma Aldrich), respectively (40 μg/mouse in 200 μL volume). For T-cell-dependent experiments, mice were boosted on day 28 with a second injection of NP-KLH. To determine anti-NP Ab concentration in response to NP-Ficoll or NP-KLH immunization, NP 30 -BSA-coated (Biosearch Technologies) ELISA plates were incubated with diluted serum, followed by HRP-conjugated anti-mouse Abs, including anti-IgM, or a mixture of anti-IgG1, IgG2a, IgG2b, and IgG3 (Southern Biotech) (11) . HRP was detected using OptEIA TMB substrate. The samples were run in triplicate and corrected for background binding. Total serum Abs were analyzed by coating ELISA plates directly with diluted serum, followed by HRP conjugated anti-mouse Abs. Relative IgG affinity from the serum of NP-KLH immunized mice was assessed as the concentration ratio of IgG bound to NP 4 -BSA versus NP 30 -BSA on day 7 and day 35 after the first immunization (12) .
Preparation of Monobiotinylated Fab' Antibody. Monobiotinylated Fab' fragment of anti-mouse Ab (mB-Fab'-anti-IgG+M) was generated from the F(ab') 2 fragment (Jackson ImmunoResearch), using a published protocol (13) . The disulfide bond that links the two Fab fragments was reduced using 2-mercaptoethylamine, and the reduced cysteine was biotinylated by maleimide activated biotin (Thermo Scientific). Fab' was further purified using Amicon Ultra centrifugal filters (Millipore). One biotin per Fab' was confirmed using a biotin quantification kit (Thermo Scientific). Fab' was labeled with AF546 (AF546-mB-Fab'-anti-IgG+M) based on the manufacturer-recommended protocol (Invitrogen).
Preparation of Ag-Tethered Planar Lipid Bilayers. Liposomes were made by combining 1,2-dioleoyl-sn-glycero-3-phosphocholine and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-cap-biotin (Avanti Polar Lipids) in a 100:1 molar ratio, using the Avanti Polar Lipids Extruder. Coverslip chambers (Nunc/Thermo Scientific) were coated with the planar lipid bilayer by incubating with the liposomes (0.05 mM) for 10 min (14) . After extensive washes, the coated coverslip chamber was incubated with 1 μg/mL streptavidin (Jackson ImmunoResearch Laboratories), followed by 1 μg/mL AF546-mB-Fab'-anti-IgG+M mixed with 4 μg/mL mB-Fab'-anti-IgG+M Ab. For a nonantigen control, surface BCRs were labeled by incubating with AF546-Fab'-anti-IgG+M (5 μg/mL) on ice for 30 min. The labeled B cells were then incubated with biotinylated holo-transferrin (Tf; 8 μg/mL, an equal molar concentration of 5 μg/mL mB-Fab′-anti-Ig+M; Sigma-Aldrich) tethered to lipid bilayers by streptavidin.
Total Internal Reflection Fluorescence Microscopic Analysis. Images were acquired using a Nikon laser total internal reflection fluorescence microscopy system on an inverted microscope (Nikon TE2000-PFS) equipped with a 60×, NA 1.49 Apochromat total internal reflection fluorescence microscopy objective (Nikon), a Coolsnap HQ2 CCD camera (Roper Scientific), and two solid-state lasers of wavelength 491 and 561 nm. Interference refection microscopic images (IRMs), AF488, and AF546 were acquired sequentially. To image intracellular molecules, B cells were incubated with mB-Fab'-anti-Ig-tethered lipid bilayers at 37°C for varying lengths of time. Cells were then fixed with 4% paraformaldehyde, permeabilized with 0.05% saponin, and stained for Abp1, HPK1 (Cell Signaling Technology), phosphorylated SHIP (Y1020; Cell Signaling Technology), phosphorylated spleen tyrosine kinase (Cell Signaling Technology), pWASP (S483/S484; Bethyl Laboratory), and pN-WASP (Y256; Millipore). F-actin was stained using AF488-phalloidin. The B-cell contact area was determined on the basis of IRM images, using MATLAB software (The MathWorks). The total (TFI) and mean fluorescence intensity (MFI) of each staining in the B-cell contact zone was determined using Andor iQ software (Andor Technology). Relative intensity of IRM and fluorescence intensity of BCRs or intracellular molecules along lines drawn across cells were measured using Andor iQ software (Andor Technology). Background fluorescence, generated by mB-Fab'-anti-Ig tethered to lipid bilayers in the absence of B cells or secondary antibody controls, was subtracted. For each set of data, more than 50 individual cells from three independent experiments were analyzed.
Confocal Microscopic Analysis. Splenic B cells were incubated with FcγR blocking mAb for 10 min on ice, stained with AF546-mB-Fab'-anti-IgG+Ma to label BCRs, washed, and activated by soluble streptavidin at 37°C. Cells were fixed at designated time with 4% paraformaldehyde and imaged with a Zeiss LSM 710 confocal Microscope (Carl Zeiss Microscopy). For each set of data, more than 50 individual cells from three independent experiments were analyzed.
Calcium Analysis. The intracellular calcium flux was measured by flow cytometry using the calcium-sensitive dyes Fluo4 and Fura Red (Molecular Probes) and manufacturer-recommended protocols. Splenic B cells were loaded with 2 μg/mL Fluo4 AM and 5 μg/mL Fura Red for 30 min at 37°C, washed, and analyzed using a FACSAria flow cytometer (BD Biosciences). The basal fluorescence intensity of Fluo4 and Fura Red were measured for 60 s before stimulation with 10 μg/mL F(ab') 2 -goat anti-mouse IgG+M (Jackson ImmunoResearch) at 37°C. The fluorescence intensity of Fluo4 and Fura Red was then measured for 300 s. The relative levels of intracellular calcium were determined by a ratio of Fluo4 to Fura Red emission values using FlowJo software (Tree Star).
Statistical Analysis. Data analysis was performed using Excel software (Microsoft) and analyzed using the Student t test. The statistical differences between groups are indicated with P values as *P < 0.05; **P < 0.01; ***P < 0.001. F(ab') 2 -goat anti-mouse IgG+M, fixed, permeabilized, stained for pN-WASP, and analyzed by flow cytometry (n = 3). *P < 0.05.
